New insulin pump aims to improve blood sugar control
NCT ID NCT07227805
First seen Nov 13, 2025 · Last updated May 09, 2026 · Updated 22 times
Summary
This study tests a new automated insulin delivery system (NMX8) in 116 people with insulin-requiring diabetes (type 1 or type 2). The goal is to see if the new system is as safe and effective as the current MiniMed 780G system at keeping blood sugar in a healthy range. Participants must already be using the 780G system.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES (INSULIN-REQUIRING, TYPE 1 OR TYPE 2) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.